Literature DB >> 8014848

Stereoselective antagonism by enantiomers of alanine and serine of phencyclidine-induced hyperactivity, stereotypy and ataxia in the rat.

Y Tanii1, T Nishikawa, A Hashimoto, K Takahashi.   

Abstract

Intracerebroventricular injection of the D-forms of alanine (Ala; 2-200 micrograms/rat) and serine (Ser; 20-2000 micrograms/rat) caused a dose-dependent inhibition of the ability of 10 mg/kg of phencyclidine (PCP; given i.p.) to increase automatically quantitated locomotor counts and cumulated scores of locomotion, stereotypy and ataxia for 90 min after PCP administration. D-Ala and D-Ser were found to be more potent than the corresponding L-isomers in attenuating the PCP-induction of these behavioral abnormalities. Although L-, but not D-Ser, at moderate doses (400 micrograms/rat) produced a slight decrease in cumulative ataxia scores after a 10-mg/kg PCP administration, D-, but not L-Ser, reduced the behavioral scores at large doses (more than 1000 micrograms/rat). Similarly, bilateral i.c.v. infusion of D-Ala (140 micrograms/rat) reduced the increasing effects of a lower dose of PCP (5 mg/kg i.p.) on locomotion, stereotypy and ataxia scores, whereas the L-form of Ala (140 micrograms/rat) lacked the inhibitory influence. The stereo-selectivity of the antagonism by Ala and Ser of PCP-induced abnormal behavior parallels that of the potencies of these amino acids as agonists for the strychnine-insensitive glycine site linked to the N-methyl-D-aspartate type excitatory amino acid receptor. Furthermore, the decreasing effects of D-Ala (200 micrograms/rat i.c.v.) and D-Ser (2000 micrograms/rat i.c.v.) on PCP-induced hyperactivity were antagonized by i.c.v. application of 5,7-dichlorokynurenate and 7-chlorokynurenate which are selective antagonists of the glycine modulatory site.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8014848

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  19 in total

Review 1.  Pharmacological treatments of cerebellar ataxia.

Authors:  Masafumi Ogawa
Journal:  Cerebellum       Date:  2004       Impact factor: 3.847

Review 2.  Modulation of NMDA receptors in the cerebellum. II. Signaling pathways and physiological modulators regulating NMDA receptor function.

Authors:  Ana Sanchez-Perez; Marta Llansola; Omar Cauli; Vicente Felipo
Journal:  Cerebellum       Date:  2005       Impact factor: 3.847

3.  Effects of selective calcium-permeable AMPA receptor blockade by IEM 1460 on psychotomimetic-induced hyperactivity in the mouse.

Authors:  Masakazu Umino; Asami Umino; Toru Nishikawa
Journal:  J Neural Transm (Vienna)       Date:  2017-12-21       Impact factor: 3.575

4.  D-amino acid oxidase activity is inhibited by an interaction with bassoon protein at the presynaptic active zone.

Authors:  Michael Popiolek; John F Ross; Erik Charych; Pranab Chanda; Eckart D Gundelfinger; Stephen J Moss; Nicholas J Brandon; Mark H Pausch
Journal:  J Biol Chem       Date:  2011-06-23       Impact factor: 5.157

5.  Glycine transporter inhibitor attenuates the psychotomimetic effects of ketamine in healthy males: preliminary evidence.

Authors:  Deepak Cyril D'Souza; Nagendra Singh; Jacqueline Elander; Michelle Carbuto; Brian Pittman; Joanna Udo de Haes; Magnus Sjogren; Pierre Peeters; Mohini Ranganathan; Jacques Schipper
Journal:  Neuropsychopharmacology       Date:  2011-11-23       Impact factor: 7.853

6.  Brain-specific Phgdh deletion reveals a pivotal role for L-serine biosynthesis in controlling the level of D-serine, an N-methyl-D-aspartate receptor co-agonist, in adult brain.

Authors:  Jung Hoon Yang; Akira Wada; Kazuyuki Yoshida; Yurika Miyoshi; Tomoko Sayano; Kayoko Esaki; Masami O Kinoshita; Shozo Tomonaga; Norihiro Azuma; Masahiko Watanabe; Kenji Hamase; Kiyoshi Zaitsu; Takeo Machida; Albee Messing; Shigeyoshi Itohara; Yoshio Hirabayashi; Shigeki Furuya
Journal:  J Biol Chem       Date:  2010-10-21       Impact factor: 5.157

7.  Modulators of the glycine site on NMDA receptors, D-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia.

Authors:  Tatiana Lipina; Viviane Labrie; Ina Weiner; John Roder
Journal:  Psychopharmacology (Berl)       Date:  2005-03-10       Impact factor: 4.530

Review 8.  The neurobiology of D-amino acid oxidase and its involvement in schizophrenia.

Authors:  L Verrall; P W J Burnet; J F Betts; P J Harrison
Journal:  Mol Psychiatry       Date:  2009-09-29       Impact factor: 15.992

9.  Pharmacological stimulation of NMDA receptors via co-agonist site suppresses fMRI response to phencyclidine in the rat.

Authors:  Alessandro Gozzi; Hugh Herdon; Adam Schwarz; Simone Bertani; Valerio Crestan; Giuliano Turrini; Angelo Bifone
Journal:  Psychopharmacology (Berl)       Date:  2008-08-15       Impact factor: 4.530

10.  Abnormally persistent latent inhibition induced by MK801 is reversed by risperidone and by positive modulators of NMDA receptor function: differential efficacy depending on the stage of the task at which they are administered.

Authors:  I Gaisler-Salomon; L Diamant; C Rubin; I Weiner
Journal:  Psychopharmacology (Berl)       Date:  2007-10-11       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.